ATACAND 16 MG COM CT BL AL PLAS TRANS X 10

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1161800950082
  • GGREM 502320090034007
  • Código de barras 5000456056410

O que a fonte publica

Detentor do registro
ASTRAZENECA DO BRASIL LTDA
Princípios ativos
CANDESARTANA CILEXETILA
Embalagem
16 MG COM CT BL AL PLAS TRANS X 10
Tipo de produto
Novo
Classe terapêutica
C9C - ANTAGONISTAS DA ANGIOTENSINA II PUROS

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:502320090034007
{
  "name": "ATACAND 16 MG COM CT BL AL PLAS TRANS X 10",
  "holder": "ASTRAZENECA DO BRASIL LTDA",
  "stripe": null,
  "barcodes": [
    "5000456056410"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "502320090034007",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "60.318.797/0001-00",
  "priceRegime": "Regulado",
  "productName": "ATACAND",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "16 MG COM CT BL AL PLAS TRANS X 10",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "51.29",
    "icms-12": "58.28",
    "icms-17": "61.80",
    "icms-18": "62.55",
    "icms-19": "63.32",
    "icms-20": "64.11",
    "icms-21": "64.92",
    "icms-22": "65.76",
    "icms-23": "66.61",
    "icms-17.5": "62.17",
    "icms-19.5": "63.71",
    "icms-20.5": "64.52",
    "icms-22.5": "66.18",
    "icms-12-alc": "57.58",
    "icms-17-alc": "61.05",
    "icms-18-alc": "61.80",
    "icms-19-alc": "62.56",
    "icms-20-alc": "63.34",
    "icms-21-alc": "64.14",
    "icms-22-alc": "64.97",
    "icms-23-alc": "65.81",
    "withoutTaxes": "50.67",
    "icms-17.5-alc": "61.42",
    "icms-19.5-alc": "62.95",
    "icms-20.5-alc": "63.74",
    "icms-22.5-alc": "65.39"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "CANDESARTANA CILEXETILA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "70.70",
    "icms-12": "80.33",
    "icms-17": "85.18",
    "icms-18": "86.22",
    "icms-19": "87.28",
    "icms-20": "88.37",
    "icms-21": "89.49",
    "icms-22": "90.64",
    "icms-23": "91.81",
    "icms-17.5": "85.69",
    "icms-19.5": "87.82",
    "icms-20.5": "88.93",
    "icms-22.5": "91.22",
    "icms-12-alc": "79.60",
    "icms-17-alc": "84.40",
    "icms-18-alc": "85.43",
    "icms-19-alc": "86.49",
    "icms-20-alc": "87.56",
    "icms-21-alc": "88.67",
    "icms-22-alc": "89.82",
    "icms-23-alc": "90.98",
    "withoutTaxes": "70.05",
    "icms-17.5-alc": "84.91",
    "icms-19.5-alc": "87.02",
    "icms-20.5-alc": "88.12",
    "icms-22.5-alc": "90.40"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "CANDESARTANA CILEXETILA"
  ],
  "therapeuticClass": "C9C - ANTAGONISTAS DA ANGIOTENSINA II PUROS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1161800950082",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "C9C",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:502320090034007"